NEW YORK, March 29, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of TrovaGene, Inc. ("TrovaGene" or "the Company") (NASDAQ: TROV). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at firstname.lastname@example.org or 212-697-6484.
This investigation concerns whether TrovaGene and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act").
On March 28, 2016, TrovaGene announced that its Board of Directors fired the Company's CEO Dr. Antonius Schuh and CFO Stephen Zaniboni and has filed a complaint against both for breaches of fiduciary duty, among other things. The Complaint alleges that Dr. Schuh and Mr. Zaniboni misled TrovaGene regarding profitable corporate opportunities and took prospects for their own personal benefit.
Following this news, TrovaGene stock dropped during intraday trading on March 29, 2016.
If you are aware of any facts relating to this investigation, or purchased shares of TrovaGene, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!trov/q0oe5. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-trovagene-inc-trov-300242777.html
SOURCE Bronstein, Gewirtz & Grossman, LLC